Cannabis use and transition to psychosis in people at ultra-high risk

The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS)

(2013) Sarah Tosato et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Evidence That Transition from Health to Psychotic Disorder Can Be Traced to Semi-Ubiquitous Environmental Effects Operating against Background Genetic Risk

(2013) Martine van Nierop et al.   PLoS One

Is cannabis neurotoxic for the healthy brain? A meta-analytical review of structural brain alterations in non-psychotic users

(2013) Matteo Rocchetti et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Age at Initiation of Cannabis Use Predicts Age at Onset of Psychosis: The 7- to 8-Year Trend

(2013) N. C. Stefanis et al.   SCHIZOPHRENIA BULLETIN

Predictors of a clinical high risk status among individuals with a family history of psychosis

(2013) Jacqueline Stowkowy et al.   SCHIZOPHRENIA RESEARCH

Predicting Psychosis

(2012) Paolo Fusar-Poli   ARCHIVES OF GENERAL PSYCHIATRY

Induction of Psychosis byΔ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing

(2012) Sagnik Bhattacharyya   ARCHIVES OF GENERAL PSYCHIATRY

Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users

(2012) Marta Di Forti et al.   BIOLOGICAL PSYCHIATRY

Potential Protective Effects of Cannabidiol on Neuroanatomical Alterations in Cannabis Users and Psychosis: A Critical Review

(2012) Derik Hermann et al.   CURRENT PHARMACEUTICAL DESIGN

Effects of Cannabis Use on Human Brain Structure in Psychosis: A Systematic Review Combining In Vivo Structural Neuroimaging and Post Mortem Studies

(2012) Charlotte Rapp et al.   CURRENT PHARMACEUTICAL DESIGN

Cannabis Use in Patients at Clinical High Risk of Psychosis: Impact on Prodromal Symptoms and Transition to Psychosis

(2012) Floor J. van der Meer et al.   CURRENT PHARMACEUTICAL DESIGN

Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function

(2012) S Bhattacharyya et al.   MOLECULAR PSYCHIATRY

Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome

(2012) A. M. Auther et al.   PSYCHOLOGICAL MEDICINE

Cannabis use in young people: The risk for schizophrenia

(2011) Paola Casadio et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Family-Based Analysis of Genetic Variation Underlying Psychosis-Inducing Effects of CannabisSibling Analysis and Proband Follow-upGenetic Variation Underlying Cannabis Effects

(2010) Ruud van Winkel   ARCHIVES OF GENERAL PSYCHIATRY

REVIEW: Genome-Wide Findings in Schizophrenia and the Role of Gene-Environment Interplay

(2010) Ruud Van Winkel et al.   CNS Neuroscience & Therapeutics

High-potency cannabis and the risk of psychosis

(2009) Marta Di Forti et al.   BRITISH JOURNAL OF PSYCHIATRY

Cannabis and First-Episode Psychosis: Different Long-term Outcomes Depending on Continued or Discontinued Use

(2009) A. Gonzalez-Pinto et al.   SCHIZOPHRENIA BULLETIN

Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad

(2008) M. Konings et al.   ACTA PSYCHIATRICA SCANDINAVICA

Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis

(2008) C CORCORAN et al.   SCHIZOPHRENIA RESEARCH